ALUPENT Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Alupent, and what generic alternatives are available?

Alupent is a drug marketed by Boehringer Ingelheim and is included in five NDAs.

The generic ingredient in ALUPENT is metaproterenol sulfate. There are six drug master file entries for this compound. Additional details are available on the metaproterenol sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Alupent

A generic version of ALUPENT was approved as metaproterenol sulfate by GENUS on July 22^nd, 1992.

Try a Trial

Summary for ALUPENT

US Patents:	0
Applicants:	1
NDAs:	5
Raw Ingredient (Bulk) Api Vendors:	39
Patent Applications:	3,828
Formulation / Manufacturing:	see details
DailyMed Link:	ALUPENT at DailyMed

Drug patent expirations by year for ALUPENT

US Patents and Regulatory Information for ALUPENT

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	AEROSOL, METERED;INHALATION	016402-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	017659-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	018761-002	Oct 10, 1986		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ALUPENT

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SOLUTION;INHALATION	017659-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	SYRUP;ORAL	017571-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	TABLET;ORAL	015874-002	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Boehringer Ingelheim	ALUPENT	metaproterenol sulfate	AEROSOL, METERED;INHALATION	016402-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ALUPENT

See the table below for patents covering ALUPENT around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Switzerland	410008	Verfahren zur Herstellung neuer Aminoalkohole	⤷ Try a Trial
Switzerland	413863	Verfahren zur Herstellung neuer Aminoalkohole	⤷ Try a Trial
Netherlands	261247		⤷ Try a Trial
Germany	1275069	1-(3', 5'-Dihydroxyphenyl)-1-hydroxy-2-isopropylaminoalkane und Verfahren zu ihrer Herstellung	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for ALUPENT

Make Better Decisions: Try a trial or see plans & pricing